🇺🇸 Benfotiamine 1050mg, 3 days in United States

Benfotiamine 1050mg, 3 days (Benfotiamine 1050mg, 3 days) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Benfotiamine 1050mg, 3 days in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Benfotiamine 1050mg, 3 days approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Benfotiamine 1050mg, 3 days in United States?

Ruhr University of Bochum is the originator. The local marketing authorisation holder may differ — check the official source linked above.